Medscape2h
Blood Tests Highly Accurate in ALS Diagnosis, Prognosis
Four serum neurofilament light chain tests show high accuracy in diagnosing ALS and predicting its progression, new research suggests.
Medical Xpress on MSN12d
Repurposed amyotrophic lateral sclerosis drug becomes imaging probe to help diagnose neurodegeneration
The researchers repurposed the drug edaravone, an antioxidant used to treat amyotrophic lateral sclerosis (ALS), as a probe ...
Science Daily1d
New clue on what is leading to neurodegenerative diseases like Alzheimer's and ALS
Researchers have revealed a new scientific clue that could unlock the key cellular pathway leading to devastating neurodegenerative diseases like Alzheimer's disease and amyotrophic lateral sclerosis ...
ALS News Today1d
Smartphone app may help in monitoring ALS beyond clinic visits
A study indicates ALS Functional Rating Scale-Revised self-assessments using a smartphone app were as reliable as those done ...
New headset reads minds and uses AR, AI and machine learning to help people with locked-in-syndrome communicate with loved ones again
Cognixion's Axon-R headset is a device designed to read brain activity using EEG as a direct input for controls. Using brain ...
Asian News International on MSN2d
MIT researchers devise process to convert skin cell directly into neurons
Working with mouse cells, the researchers developed a highly efficient conversion method that can produce more than 10 ...
Mother with rare ALS touts ‘miracle drug’ that has stopped her disease
Eight years after receiving a life-shattering diagnosis, a New Jersey mother credits an “amazing” new drug for stopping her ...
Coya Therapeutics Provides a Corporate Update and Reports Fiscal 2024 Financial Results
Coya Therapeutics, Inc. (Nasdaq: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company developing biologics intended to enhance regulatory T cell (Treg) function, provides a ...
Decreased levels of TDP-43 gene may be contributing to neurodegenerative diseases like Alzheimer's and ALS
In Nature Neuroscience, UConn School of Medicine researchers have revealed a new scientific clue that could unlock the key ...
Local vector-borne disease expert who led US West Nile virus response dead at 73
John Roehrig died March 8 after a battle with ALS. During his career, he was on the front lines of the U.S. response to West Nile virus.
Fierce Biotech3h
Arbor sails into rocky gene editing waters with $74M for rare liver disease therapy
As other gene editing programs fold or get sold, Arbor Biotechnologies has secured $73.9 million to advance its lead liver-targeting gene therapy into human trials. | As other gene editing programs ...